Publications of M. Uhr
All genres
Journal Article (285)
281.
Journal Article
70, pp. 431 - 438 (1999)
Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis. Neuroendocrinology 282.
Journal Article
179, pp. 1047 - 1048 (1999)
Salmonella abortus equi endotoxin does not affect leptin plasma levels in healthy humans (and reply). Journal of Infectious Diseases 283.
Journal Article
316, pp. 577 - 582 (1998)
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: Prospective case-control study. British Medical Journal 284.
Journal Article
53, pp. 287 - 294 (1998)
Aromatic alcohols as neuroprotectants. Journal of Neural Transmission, Suppl. 285.
Journal Article
413, pp. 467 - 472 (1997)
Neuroprotective potential of aromatic alcohols against oxidative cell death. FEBS Letters Book Chapter (5)
286.
Book Chapter
Special Serum Analysis. In: Laboratory Diagnosis in Neurology, pp. 81 - 85. Thieme, Stuttgart [et.al] (2010)
287.
Book Chapter
Psychiatric Disorders. In: Laboratory Diagnosis in Neurology, pp. 176 - 178. Thieme, Stuttgart [et.al] (2010)
288.
Book Chapter
Decreased corticotropin-releasing hormone (CRH) concentrations in the cerebrospinal fluid of eucortisolemic suicide attempters. In: Suicide Risk and Protective Factors in the New Millennium, pp. 131 - 135 (Ed. Grad, O. T.). Cankarjev dom, Ljubljana (2001)
289.
Book Chapter
Bronisch, T.; Felber, W.; Wolfersdorf, M.). Roderer, Regensburg (2001)
Parameter des Hypothalamus-Hypophysen-Nebennierenrinden-Systems im Liquor und im Plasma bei Patienten nach Suizidversuch und mit Suizidideen. In: Neurobiologie suizidalen Verhaltens, pp. 161 - 181 (Eds. 290.
Book Chapter
Echinokokkose. In: Infektionserkrankungen des Zentralnervensystems. Pathogenese, Diagnose und Therapie, pp. 485 - 508 (Eds. Prange, H.; Bitsch, A.). Wissenschaftliche Verlagsgesellschaft, Stuttgart (2001)
Conference Paper (6)
291.
Conference Paper
83 (9, Suppl.), S74, pp. S375 - S376 (2018)
Perspective of Personalized Drug Treatment in Depression. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, May 10, 2018 - May 12, 2018. BIOLOGICAL PSYCHIATRY 292.
Conference Paper
124 (10), 161, p. 1296 - 1296 (2017)
Stress and neurovascular coupling: A new reciprocal mechanism for stress response regulation. Conference of the
World Association for Stress Related and Anxiety Disorders (WASAD), Würzburg, GERMANY, September 14, 2017 - September 16, 2017. JOURNAL OF NEURAL TRANSMISSION 293.
Conference Paper
27 (Suppl. 4), S.16.06, pp. S547 - S548 (2017)
Acute psychosocial stress impacts the hemodynamic response latency: a novel brain-phenotype of acute stress and GR-sensitivity. 30th Congress of the European College of Neuropsychopharmacology (ECNP), Paris, FRANCE, September 02, 2017 - September 05, 2017. EUROPEAN NEUROPSYCHOPHARMACOLOGY 294.
Conference Paper
81 (10, Suppl.), 566, p. S229 - S229 (2017)
Acute Psychosocial Stress Impacts the Hemodynamic Response latency: A Novel Brain Phenotype that Relates to Markers of Acute and Chronic Stress. 72nd Annual Scientific Convention and Meeting of the
Society of Biological Psychiatry (SOBP), San Diego, CA, May 18, 2017 - May 20, 2017. BIOLOGICAL PSYCHIATRY 295.
Conference Paper
27 (Suppl. 1), P.3.021, pp. S68 - S69 (2017)
Acute psychosocial stress impacts the hemodynamic response latency: a novel brain-phenotype of acute and chronic stress. European College of Neuropsychopharmacology (ECNP) Workshop for Junior
Scientists in Europe, Nice, FRANCE, March 09, 2017 - March 12, 2017. EUROPEAN NEUROPSYCHOPHARMACOLOGY 296.
Conference Paper
81 (10, Suppl.), p. S226 - S226 (2017)
CRH R1 Genotype and Sleep Electroencepahlogram in Healthy Subjects. 72nd Annual Scientific Convention and Meeting of the Society of Biological Psychiatry (SOBP), San Diego, CA, May 18, 2017 - May 20, 2017. BIOLOGICAL PSYCHIATRY Meeting Abstract (22)
297.
Meeting Abstract
29, pp. 892 - 893. 9th Joint ECTRIMS-ACTRIMS meeting, Milan, ITALY, October 11, 2023 - October 13, 2023. (2023)
Serum interleukin 16 levels probed as predictor of longitudinal global and regional brain volume and lesion volume changes in multiple sclerosis. In MULTIPLE SCLEROSIS JOURNAL, 298.
Meeting Abstract
55 (03), pp. 172 - 173. (2022)
The therapeutic reference range for olanzapine revised - how to combine old and new findings. In PHARMACOPSYCHIATRY, 299.
Meeting Abstract
21 (10), pp. 766 - 774. (2020)
Evidence for an enhanced procoagulant state in remitted major depression. In WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 300.
Meeting Abstract
29, pp. S46 - S47. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, October 06, 2018 - October 09, 2018. (2019)
Perspective of personalised drug treatment in depression. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,